Director of Microbiology at Paratek Pharmaceuticals with over 20 years of experience in antibacterial research and development.
I received a B.S. in Medical Technology from Northeastern University and began my career as a Medical Technologist working in the clinical microbiology laboratory for several years before transitioning to the pharmaceutical industry. Prior to joining Paratek, I spent 13 years with Cubist Pharmaceuticals, developing Cubicin and Zerbaxa.
My primary areas of responsibility include, leading the Paratek Keystone Surveillance Program, managing antimicrobial susceptibility testing development, clinical trial development and writing support of regulatory submissions.
I am a member of the American Society of Microbiology and Infectious Disease Society of America.